Fundraising FoxAxil Capital — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
BiotechMedford, US
Giovanni Traverso(Director)inRobert Langer(Director)Carl Schoellhammer(Executive Officer, Director)inAmy Schulman(Director)
Co-investorsTaiwania Capital
TechsoMed develops BioTrace, an FDA-cleared software platform for image-guided minimally invasive cancer therapy that uses AI to provide real-time 3D visualization, tumor margin control, needle path planning, and post-ablation tissue response prediction.
AI & Machine LearningDigital HealthMedical Devices
Co-investorsNextLeap VenturesHelios Climate Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.